Trial Profile
Effect of Different Concentrations of SPARC1102 on Allergic Conjunctivitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Jun 2016
Price :
$35
*
At a glance
- Drugs SUN 1334H (Primary)
- Indications Allergic conjunctivitis
- Focus Therapeutic Use
- Sponsors Sun Pharma Advanced Research Company
- 25 Jun 2014 New trial record